scholarly journals Empagliflozin as add-on to linagliptin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52-week, randomized, placebo-controlled trial

2018 ◽  
Vol 20 (9) ◽  
pp. 2200-2209 ◽  
Author(s):  
Ryuzo Kawamori ◽  
Masakazu Haneda ◽  
Keiko Suzaki ◽  
Gang Cheng ◽  
Kosuke Shiki ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document